Citigroup’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-47,601
Closed -$732K 6060
2025
Q4
$732K Sell
47,601
-29,302
-38% -$323K ﹤0.01% 3339
2025
Q3
$764K Sell
76,903
-119,373
-61% -$1.24M ﹤0.01% 3334
2025
Q2
$1.95M Sell
196,276
-113,456
-37% -$1.2M ﹤0.01% 2674
2025
Q1
$4.02M Buy
309,732
+22,155
+8% +$293K ﹤0.01% 2108
2024
Q4
$3.67M Buy
287,577
+94,991
+49% +$1.15M ﹤0.01% 2266
2024
Q3
$2.15M Buy
192,586
+50,047
+35% +$552K ﹤0.01% 2603
2024
Q2
$1.6M Sell
142,539
-521,988
-79% -$6.08M ﹤0.01% 2538
2024
Q1
$8.25M Buy
664,527
+191,464
+40% +$2.5M 0.01% 1362
2023
Q4
$6.61M Buy
473,063
+218,124
+86% +$3.03M ﹤0.01% 1426
2023
Q3
$3.77M Buy
254,939
+47,771
+23% +$672K ﹤0.01% 1581
2023
Q2
$2.68M Sell
207,168
-282,481
-58% -$3.22M ﹤0.01% 1951
2023
Q1
$4.8M Buy
489,649
+126,979
+35% +$1.36M ﹤0.01% 1525
2022
Q4
$3.86M Sell
362,670
-236,734
-39% -$2.75M ﹤0.01% 1611
2022
Q3
$6.26M Buy
599,404
+277,357
+86% +$3.61M ﹤0.01% 1416
2022
Q2
$4.05M Buy
322,047
+228,377
+244% +$2.43M ﹤0.01% 1655
2022
Q1
$1.02M Sell
93,670
-228,876
-71% -$2.78M ﹤0.01% 2934
2021
Q4
$4.54M Sell
322,546
-71,918
-18% -$1.18M ﹤0.01% 1908
2021
Q3
$7.58M Sell
394,464
-39,465
-9% -$524K ﹤0.01% 1558
2021
Q2
$4.27M Buy
433,929
+3,130
+0.7% +$28.5K ﹤0.01% 2034
2021
Q1
$4.24M Buy
430,799
+382,817
+798% +$3.16M ﹤0.01% 1899
2020
Q4
$214K Sell
47,982
-122,174
-72% -$553K ﹤0.01% 4938
2020
Q3
$735K Buy
170,156
+47,440
+39% +$338K ﹤0.01% 3542
2020
Q2
$1.09M Sell
122,716
-6,352
-5% -$32.1K ﹤0.01% 3474
2020
Q1
$456K Buy
129,068
+43,514
+51% +$202K ﹤0.01% 3947
2019
Q4
$489K Sell
85,554
-54,860
-39% -$293K ﹤0.01% 4435
2019
Q3
$502K Buy
140,414
+8,370
+6% +$32.4K ﹤0.01% 4340
2019
Q2
$527K Buy
132,044
+86,265
+188% +$500K ﹤0.01% 4370
2019
Q1
$335K Sell
45,779
-395,529
-90% -$3.87M ﹤0.01% 4590
2018
Q4
$4.04M Buy
441,308
+191,111
+76% +$2.12M ﹤0.01% 2009
2018
Q3
$3.1M Buy
250,197
+66,940
+37% +$906K ﹤0.01% 2314
2018
Q2
$2.79M Buy
183,257
+170,277
+1,312% +$2.94M ﹤0.01% 2398
2018
Q1
$258K Sell
12,980
-434,708
-97% -$7.51M ﹤0.01% 4683
2017
Q4
$8.37M Sell
447,688
-264,432
-37% -$5.31M 0.01% 1415
2017
Q3
$15.3M Buy
712,120
+711,796
+219,690% +$11.3M 0.01% 945
2017
Q2
$3K Sell
324
-3,431
-91% -$22.3K ﹤0.01% 6874
2017
Q1
$23K Sell
3,755
-1,319
-26% -$6.34K ﹤0.01% 6177
2016
Q4
$20K Buy
5,074
+3,753
+284% +$27.5K ﹤0.01% 6520
2016
Q3
$14K Sell
1,321
-950
-42% -$13.7K ﹤0.01% 6382
2016
Q2
$33K Sell
2,271
-24,327
-91% -$416K ﹤0.01% 5831
2016
Q1
$512K Sell
26,598
-81,441
-75% -$1.65M ﹤0.01% 4092
2015
Q4
$2.61M Sell
108,039
-19,337
-15% -$484K ﹤0.01% 2278
2015
Q3
$3.13M Buy
127,376
+73,213
+135% +$2.07M ﹤0.01% 2078
2015
Q2
$1.27M Buy
54,163
+49,375
+1,031% +$1.08M ﹤0.01% 2969
2015
Q1
$108K Sell
4,788
-5,333
-53% -$102K ﹤0.01% 4976
2014
Q4
$170K Buy
10,121
+4,531
+81% +$69K ﹤0.01% 4819
2014
Q3
$80K Sell
5,590
-2,587
-32% -$37.3K ﹤0.01% 4940
2014
Q2
$130K Sell
8,177
-1,488
-15% -$22.4K ﹤0.01% 4475
2014
Q1
$174K Sell
9,665
-4,767
-33% -$88.4K ﹤0.01% 4474
2013
Q4
$282K Buy
14,432
+11,074
+330% +$162K ﹤0.01% 4344
2013
Q3
$40K Buy
3,358
+1,306
+64% +$16.4K ﹤0.01% 5436
2013
Q2
$23K Buy
+2,052
New +$43.2K ﹤0.01% 5764

Other funds holding DVAX

Citigroup's DVAX Position: Q1 2026 in Review

Citigroup sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 47,601 shares — an estimated $732K sold.

Citigroup first reported a position in DVAX in Q2 2013 and held it in 51 quarters. The position peaked at $15.3M in Q3 2017. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Citigroup reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 47,601 Dynavax Technologies shares in Q1 2026, an estimated $732K.
  • Citigroup first reported a position in Dynavax Technologies in Q2 2013 and held it in 51 quarters.
  • Citigroup's Dynavax Technologies position peaked at $15.3M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.